To improve the performance of our website, show the most relevant news products and targeted advertising, we collect technical impersonal information about you, including through the tools of our partners. You can find a detailed description of how we use your data in our Privacy Policy. For a detailed description of the technologies, please see the Cookie and Automatic Logging Policy.
By clicking on the Accept & Close button, you provide your explicit consent to the processing of your data to achieve the above goal.
You can withdraw your consent using the method specified in the Privacy Policy.
Accept & Close
Sputnik International
Single-shot Johnson & Johnson vaccine 66 percent effective against moderate and severe illness washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.
RDIF and the Gamaleya Center announce International scientific advisory board on Sputnik V vaccine Russian Direct Investment Fund 426 Russian Direct Investment Fund 19 January 2021 14:54 The Russian Direct Investment Fund (RDIF, Russia s sovereign wealth fund) and The National Research Center for Epidemiology and Microbiology named after N.F. Gamaleya (Gamaleya Center) announce the creation of an International Scientific Advisory Board on the Sputnik V vaccine – the world s first registered vaccine against coronavirus. Leading scientists in virology, microbiology, genetics and biotechnology fr om Argentina, Croatia, France, Germany, India, Russia, Sweden, UK and USA, representing top research and medical centers, have joined the Board.